社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
晶泰控股(02228)
9.340
-0.630
-6.32%
行情数据延迟15分钟
社区
社区
资讯
资讯
资料
资料
公告
公告
最新
推荐
Gudrun
·
15:01
$晶泰控股(02228)$
晶泰药物发现解决方案实现收入人民币5.38亿元,涵盖小分子药物、生物大分子及新型多肽等研发管线,与全球领先制药企业及前沿生物科技公司建立多种合作模式。
$晶泰控股(02228)$ 晶泰药物发现解决方案实现收入人民币5.38亿元,涵盖小分子药物、生物大分子及新型多肽等研发管线,与全球领先制药企业及前沿生物科...
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
六一玖中路
·
04-21 23:01
$晶泰控股(02228)$
近期股价下跌主要受市场整体环境、资金面分歧以及投资者对高成长股估值回归等因素影响
$晶泰控股(02228)$ 近期股价下跌主要受市场整体环境、资金面分歧以及投资者对高成长股估值回归等因素影响
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
股市的尔虞我诈
·
04-21 13:54
$晶泰控股(02228)$
买单开始大量买入,股价下午要冲上来10块
$晶泰控股(02228)$ 买单开始大量买入,股价下午要冲上来10块
回复
评论
点赞
1
编组 21备份 2
分享
举报
Gudrun
·
04-20 14:50
$晶泰控股(02228)$
于截至2025年12月31日止年度,晶泰控股(02228)收入达人民币8.03亿元,较上一年度的2.66亿元同比增长逾两倍。集团年内利润成功扭转2024年亏损15.15亿元的局面,实现人民币1.35亿元的正向收益,其中归属于公司权益持有人的利润为1.24亿元。
$晶泰控股(02228)$ 于截至2025年12月31日止年度,晶泰控股(02228)收入达人民币8.03亿元,较上一年度的2.66亿元同比增长逾两倍。集...
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
曼曼在海南
·
04-17
$晶泰控股(02228)$
全球生物医药投融资复苏为行业带来贝塔机会,而晶泰控股独特的技术平台和已验证的盈利模式则构成了其超越行业的阿尔法价值
$晶泰控股(02228)$ 全球生物医药投融资复苏为行业带来贝塔机会,而晶泰控股独特的技术平台和已验证的盈利模式则构成了其超越行业的阿尔法价值
回复
评论
点赞
1
编组 21备份 2
分享
举报
行稳致远之
·
04-16
$晶泰控股(02228)$
晶泰又开始回到10块以上了,回到熟悉的区间会安稳很多
$晶泰控股(02228)$ 晶泰又开始回到10块以上了,回到熟悉的区间会安稳很多
回复
评论
点赞
1
编组 21备份 2
分享
举报
电白小白15
·
04-15
$晶泰控股(02228)$
AI赋能药物研发是明确的产业趋势,公司作为该领域的平台型龙头,其成长路径和商业模式日益清晰
$晶泰控股(02228)$ AI赋能药物研发是明确的产业趋势,公司作为该领域的平台型龙头,其成长路径和商业模式日益清晰
回复
评论
点赞
1
编组 21备份 2
分享
举报
港股解码
·
15:32
范式智能(06682.HK)再配股筹超15亿,盈利拐点后为何仍“补血”?
港股AI龙头
$范式智能(06682)$
在交出首份盈利年报后,迅速抛出了新一轮融资计划。4月22日早间,公司公告拟按每股40.36港元(较上一交易日45.84港元的收盘价折让11.95%)配售最多3880万股新H股,预计净筹约15.56亿港元,全部投向AI算力基础设施与新兴业务扩张。 面对如此大额折让配售,二级市场投资者直接用脚投票,走为上策。4月22日,截至发稿,公司股价大跌12.78%,领跌港股AI板块,
$哔哩哔哩-W(09626)$
、
$迈富时(02556)$
、
$晶泰控股(02228)$
、
$美图公司(01357)$
等股也录得较大跌幅。 实际上,这已是范式智能自2025年以来的第三次大额配股,累计募资规模将超过42亿港元。在行业普遍面临算力短缺、竞争白热化的背景下,这家连续七年稳居中国机器学习平台市场份额第一的企业,正通过持续的资本投入构建技术护城河,但频繁融资也引发了市场对其股权稀释与资金使用效率的担忧。 一年多三度配股,All in硬科技与全球化 根据公告,本次配售股份占范式智能现有已发行H股的12.09%、总股份的7.47%,配售完成后H股占比将从61.73%提升至64.39%。 定价方面,40.36港元的配售价较4月21日收盘价45.84港元折让11.95%,较前5个交易日均价折让6.03%,但较前30个交易日均价溢价6.39%,这一定价策略考
范式智能(06682.HK)再配股筹超15亿,盈利拐点后为何仍“补血”?
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
股市时光机
·
04-15
$晶泰控股(02228)$
股价走势越来越强,本周价格看来要破15块
$晶泰控股(02228)$ 股价走势越来越强,本周价格看来要破15块
回复
评论
点赞
1
编组 21备份 2
分享
举报
股市的尔虞我诈
·
04-14
$晶泰控股(02228)$
股价开始逆袭了!下午回去10块
$晶泰控股(02228)$ 股价开始逆袭了!下午回去10块
回复
评论
点赞
1
编组 21备份 2
分享
举报
加载更多
公司概况
公司名称
晶泰控股
所属市场
SEHK
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
https://www.xtalpi.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
晶泰控股有限公司是一家主要从事为制药及材料科学等产业提供药物及材料科学研发解决方案及服务的控股公司。该公司主要经营两个业务。药物发现解决方案业务从事就新型药物发现工作为各类生物技术与制药公司和学术机构提供模块独立解决方案或与之合作。智能自动化解决方案业务从事提供固态研发服务及自动化化学合成服务。该公司在国内和国外市场开展业务。
04-17
股份购回
建议授出一般授权以购回股份及发行股份、重新委任核数师、重选董事建议采纳新组织章程大纲及细则、建议采纳2026年股份计划;及股东周年大会通告
建议授出一般授权以购回股份及发行股份、重新委任核数师、重选董事建议采纳新组织章程大纲及细则、建议采纳2026年股份计划;及股东周年大会通告
04-17
年度报告
2025年度报告
2025年度报告
03-25
年度报告
截至2025年12月31日止年度的年度业绩公告
截至2025年12月31日止年度的年度业绩公告
03-03
业绩预告
正面盈利预告扭亏为盈
正面盈利预告扭亏为盈
01-28
股份发行
完成发行2,866,000,000港元于2027年到期的零息可转换债券
完成发行2,866,000,000港元于2027年到期的零息可转换债券
01-08
股份发行
建议发行2,866,000,000港元于2027年到期的零息可转换债券
建议发行2,866,000,000港元于2027年到期的零息可转换债券
2025-09-16
半年度报告
2025中期报告
2025中期报告
2025-09-16
半年度报告
有关截至2025年6月30日止六个月的中期业绩公告的澄清公告
有关截至2025年6月30日止六个月的中期业绩公告的澄清公告
2025-09-04
股份发行
完成根据一般授权配售新股份
完成根据一般授权配售新股份
2025-08-29
股份发行
根据一般授权配售新股份
根据一般授权配售新股份
2025-08-27
半年度报告
截至2025年6月30日止六个月的中期业绩公告
截至2025年6月30日止六个月的中期业绩公告
2025-08-12
业绩预告
正面盈利预告
正面盈利预告
2025-05-11
须予披露的交易
有关收购目标公司90%股权之须予披露交易
有关收购目标公司90%股权之须予披露交易
2025-04-07
股份购回
建议授出一般授权以发行股份及购回股份、重新委任核数师、重选董事及股东周年大会通告
建议授出一般授权以发行股份及购回股份、重新委任核数师、重选董事及股东周年大会通告
2025-04-07
年度报告
2024年度报告
2024年度报告
分时
5日
日
周
月
数据加载中...
最高
9.900
今开
9.880
量比
1.59
最低
9.300
昨收
9.970
换手率
2.07%
热议股票
{"pagemeta":{"title":"晶泰控股(02228)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供晶泰控股(02228)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"晶泰控股,02228,晶泰控股股票,晶泰控股股票老虎,晶泰控股股票老虎国际,晶泰控股行情,晶泰控股股票行情,晶泰控股股价,晶泰控股股市,晶泰控股股票价格,晶泰控股股票交易,晶泰控股股票购买,晶泰控股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"晶泰控股(02228)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供晶泰控股(02228)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"community","symbol":"02228","data":{"stockData":{"symbol":"02228","market":"HK","secType":"STK","nameCN":"晶泰控股","latestPrice":9.34,"timestamp":1776845310003,"preClose":9.97,"halted":0,"volume":89136713,"delay":0,"changeRate":-0.06318956870611843,"floatShares":4303000000,"shares":4303000000,"eps":0.034402525082433286,"marketStatus":"已收盘","change":-0.63,"latestTime":"04-22 16:08:30","open":9.88,"high":9.9,"low":9.3,"amount":846897078,"amplitude":0.060181,"askPrice":9.34,"askSize":55000,"bidPrice":9.33,"bidSize":171000,"shortable":3,"etf":0,"ttmEps":0.034402525082433286,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1776907800000},"marketStatusCode":5,"adr":0,"listingDate":1718208000000,"exchange":"SEHK","adjPreClose":9.97,"openAndCloseTimeList":[[1776821400000,1776830400000],[1776834000000,1776844800000]],"volumeRatio":1.591162,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"tweetData":{"bottom":false,"list":[{"cardType":"TWEET","cardId":"TWEET.556288959338368","cardData":[{"tweetId":"556288959338368","author":{"authorId":"4108172460082090","idStr":"4108172460082090","name":"Gudrun","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":22,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$ </a> 晶泰药物发现解决方案实现收入人民币5.38亿元,涵盖小分子药物、生物大分子及新型多肽等研发管线,与全球领先制药企业及前沿生物科技公司建立多种合作模式。","plainDigest":"$晶泰控股(02228)$ 晶泰药物发现解决方案实现收入人民币5.38亿元,涵盖小分子药物、生物大分子及新型多肽等研发管线,与全球领先制药企业及前沿生物科技公司建立多种合作模式。","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1776841311093,"gmtModify":1776842045980,"symbols":["02228"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":22,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/556288959338368","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":159,"displayRows":4,"foldSize":0,"authorId":"4108172460082090"}]},{"cardType":"TWEET","cardId":"TWEET.556053247333008","cardData":[{"tweetId":"556053247333008","author":{"authorId":"3564011840073775","idStr":"3564011840073775","name":"六一玖中路","avatar":"https://static.tigerbbs.com/a37cb08394c3dc27fb59f07921d7c74f","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":8,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$ </a>近期股价下跌主要受市场整体环境、资金面分歧以及投资者对高成长股估值回归等因素影响","plainDigest":"$晶泰控股(02228)$ 近期股价下跌主要受市场整体环境、资金面分歧以及投资者对高成长股估值回归等因素影响","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1776783692073,"gmtModify":1776783694163,"symbols":["02228"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":198,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/556053247333008","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":99,"displayRows":4,"foldSize":0,"authorId":"3564011840073775"}]},{"cardType":"TWEET","cardId":"TWEET.555899412990080","cardData":[{"tweetId":"555899412990080","author":{"authorId":"4109854578477180","idStr":"4109854578477180","name":"股市的尔虞我诈","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":31,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$ </a>买单开始大量买入,股价下午要冲上来10块","plainDigest":"$晶泰控股(02228)$ 买单开始大量买入,股价下午要冲上来10块","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1776750877886,"gmtModify":1776750880125,"symbols":["02228"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":135,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/555899412990080","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":54,"displayRows":4,"foldSize":0,"authorId":"4109854578477180"}]},{"cardType":"TWEET","cardId":"TWEET.555553487263760","cardData":[{"tweetId":"555553487263760","author":{"authorId":"4108172460082090","idStr":"4108172460082090","name":"Gudrun","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":22,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$ </a> 于截至2025年12月31日止年度,晶泰控股(02228)收入达人民币8.03亿元,较上一年度的2.66亿元同比增长逾两倍。集团年内利润成功扭转2024年亏损15.15亿元的局面,实现人民币1.35亿元的正向收益,其中归属于公司权益持有人的利润为1.24亿元。","plainDigest":"$晶泰控股(02228)$ 于截至2025年12月31日止年度,晶泰控股(02228)收入达人民币8.03亿元,较上一年度的2.66亿元同比增长逾两倍。集团年内利润成功扭转2024年亏损15.15亿元的局面,实现人民币1.35亿元的正向收益,其中归属于公司权益持有人的利润为1.24亿元。","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1776667814354,"gmtModify":1776667977774,"symbols":["02228"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":79,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/555553487263760","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":231,"displayRows":4,"foldSize":0,"authorId":"4108172460082090"}]},{"cardType":"TWEET","cardId":"TWEET.554442815063088","cardData":[{"tweetId":"554442815063088","author":{"authorId":"4184381897673700","idStr":"4184381897673700","name":"曼曼在海南","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":7,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$ </a> 全球生物医药投融资复苏为行业带来贝塔机会,而晶泰控股独特的技术平台和已验证的盈利模式则构成了其超越行业的阿尔法价值","plainDigest":"$晶泰控股(02228)$ 全球生物医药投融资复苏为行业带来贝塔机会,而晶泰控股独特的技术平台和已验证的盈利模式则构成了其超越行业的阿尔法价值","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1776396585149,"gmtModify":1776396587206,"symbols":["02228"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":314,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/554442815063088","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":130,"displayRows":4,"foldSize":0,"authorId":"4184381897673700"}]},{"cardType":"TWEET","cardId":"TWEET.554233936040064","cardData":[{"tweetId":"554233936040064","author":{"authorId":"3574483855983034","idStr":"3574483855983034","name":"行稳致远之","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","crmLevel":2,"crmLevelSwitch":0,"wearingBadge":{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"wearingBadges":[{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","name":"实盘交易者","description":"完成一笔实盘交易","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","isScarce":0,"effectEnabled":0,"redirectLinkEnabled":0,"redirectLinkValidityFrom":0,"redirectLinkValidityTo":9223372036854776000}],"fanSize":28,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$</a> 晶泰又开始回到10块以上了,回到熟悉的区间会安稳很多","plainDigest":"$晶泰控股(02228)$ 晶泰又开始回到10块以上了,回到熟悉的区间会安稳很多","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1776345682899,"gmtModify":1776345684847,"symbols":["02228"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":206,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/554233936040064","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":66,"displayRows":4,"foldSize":0,"authorId":"3574483855983034"}]},{"cardType":"TWEET","cardId":"TWEET.553824473757392","cardData":[{"tweetId":"553824473757392","author":{"authorId":"4218363023229180","idStr":"4218363023229180","name":"电白小白15","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":4,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$ </a> AI赋能药物研发是明确的产业趋势,公司作为该领域的平台型龙头,其成长路径和商业模式日益清晰","plainDigest":"$晶泰控股(02228)$ AI赋能药物研发是明确的产业趋势,公司作为该领域的平台型龙头,其成长路径和商业模式日益清晰","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1776245689841,"gmtModify":1776245692240,"symbols":["02228"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":160,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/553824473757392","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":103,"displayRows":4,"foldSize":0,"authorId":"4218363023229180"}]},{"cardType":"TWEET","cardId":"TWEET.556296483047472","cardData":[{"tweetId":"556296483047472","author":{"authorId":"3478560277044805","idStr":"3478560277044805","name":"港股解码","avatar":"https://static.tigerbbs.com/0ddf8b49991624b6c7a49b9c67324a01","userType":2,"introduction":"港股解码,香港财华社原创王牌专栏,金融名家齐聚。看完记得订阅、评论、点赞哦。","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":3962,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"范式智能(06682.HK)再配股筹超15亿,盈利拐点后为何仍“补血”?","digest":"港股AI龙头 <a href=\"https://laohu8.com/S/06682\">$范式智能(06682)$</a> 在交出首份盈利年报后,迅速抛出了新一轮融资计划。4月22日早间,公司公告拟按每股40.36港元(较上一交易日45.84港元的收盘价折让11.95%)配售最多3880万股新H股,预计净筹约15.56亿港元,全部投向AI算力基础设施与新兴业务扩张。 面对如此大额折让配售,二级市场投资者直接用脚投票,走为上策。4月22日,截至发稿,公司股价大跌12.78%,领跌港股AI板块, <a href=\"https://laohu8.com/S/09626\">$哔哩哔哩-W(09626)$</a> 、 <a href=\"https://laohu8.com/S/02556\">$迈富时(02556)$</a> 、 <a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$</a> 、 <a href=\"https://laohu8.com/S/01357\">$美图公司(01357)$</a> 等股也录得较大跌幅。 实际上,这已是范式智能自2025年以来的第三次大额配股,累计募资规模将超过42亿港元。在行业普遍面临算力短缺、竞争白热化的背景下,这家连续七年稳居中国机器学习平台市场份额第一的企业,正通过持续的资本投入构建技术护城河,但频繁融资也引发了市场对其股权稀释与资金使用效率的担忧。 一年多三度配股,All in硬科技与全球化 根据公告,本次配售股份占范式智能现有已发行H股的12.09%、总股份的7.47%,配售完成后H股占比将从61.73%提升至64.39%。 定价方面,40.36港元的配售价较4月21日收盘价45.84港元折让11.95%,较前5个交易日均价折让6.03%,但较前30个交易日均价溢价6.39%,这一定价策略考","plainDigest":"港股AI龙头 $范式智能(06682)$ 在交出首份盈利年报后,迅速抛出了新一轮融资计划。4月22日早间,公司公告拟按每股40.36港元(较上一交易日45.84港元的收盘价折让11.95%)配售最多3880万股新H股,预计净筹约15.56亿港元,全部投向AI算力基础设施与新兴业务扩张。 面对如此大额折让配售,二级市场投资者直接用脚投票,走为上策。4月22日,截至发稿,公司股价大跌12.78%,领跌港股AI板块, $哔哩哔哩-W(09626)$ 、 $迈富时(02556)$ 、 $晶泰控股(02228)$ 、 $美图公司(01357)$ 等股也录得较大跌幅。 实际上,这已是范式智能自2025年以来的第三次大额配股,累计募资规模将超过42亿港元。在行业普遍面临算力短缺、竞争白热化的背景下,这家连续七年稳居中国机器学习平台市场份额第一的企业,正通过持续的资本投入构建技术护城河,但频繁融资也引发了市场对其股权稀释与资金使用效率的担忧。 一年多三度配股,All in硬科技与全球化 根据公告,本次配售股份占范式智能现有已发行H股的12.09%、总股份的7.47%,配售完成后H股占比将从61.73%提升至64.39%。 定价方面,40.36港元的配售价较4月21日收盘价45.84港元折让11.95%,较前5个交易日均价折让6.03%,但较前30个交易日均价溢价6.39%,这一定价策略考","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1776843149139,"gmtModify":1776847026862,"symbols":["02556","01357","06682","02228","09626","BILI"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":4,"images":[{"url":"https://static.tigerbbs.com/8bd14cff1e6f9fda70736e131031c1bb","width":"1269","height":"840"}],"repostCount":0,"viewCount":270,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/556296483047472","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":3890,"displayRows":4,"foldSize":0,"authorId":"3478560277044805"}]},{"cardType":"TWEET","cardId":"TWEET.553740685431320","cardData":[{"tweetId":"553740685431320","author":{"authorId":"4108085372061810","idStr":"4108085372061810","name":"股市时光机","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":12,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$ </a> 股价走势越来越强,本周价格看来要破15块","plainDigest":"$晶泰控股(02228)$ 股价走势越来越强,本周价格看来要破15块","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1776225163610,"gmtModify":1776225165597,"symbols":["02228"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":206,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/553740685431320","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":54,"displayRows":4,"foldSize":0,"authorId":"4108085372061810"}]},{"cardType":"TWEET","cardId":"TWEET.553430696047600","cardData":[{"tweetId":"553430696047600","author":{"authorId":"4109854578477180","idStr":"4109854578477180","name":"股市的尔虞我诈","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":31,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$ </a> 股价开始逆袭了!下午回去10块","plainDigest":"$晶泰控股(02228)$ 股价开始逆袭了!下午回去10块","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1776149555493,"gmtModify":1776149557536,"symbols":["02228"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":306,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/553430696047600","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":44,"displayRows":4,"foldSize":0,"authorId":"4109854578477180"}]}],"size":10},"newsData":null,"noticeData":{"listData":[{"cdn_pdf":true,"hasAttachments":false,"id":"21024850","market":"hk","labels":[],"media":"港交所","original_id":"N.HK7XYwiaaS4g","pdf_url":"https://static.tigerbbs.com/97cb00a1170c4ea98d78f91ca4a13164","pub_time":1776430500000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"建议授出一般授权以购回股份及发行股份、重新委任核数师、重选董事建议采纳新组织章程大纲及细则、建议采纳2026年股份计划;及股东周年大会通告","symbol":"02228","title":"建议授出一般授权以购回股份及发行股份、重新委任核数师、重选董事建议采纳新组织章程大纲及细则、建议采纳2026年股份计划;及股东周年大会通告","titleType":"股份购回","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2026/0417/2026041701564_c.pdf","us_notice_code":"通函 - [一般性授权 / 在股东批准的情况下重选或委任董事 / 回购股份的说明函件 / 修订宪章文件 / 股份计划]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Repurchase","event_type":"important_notice","event_name":"股份购回","pubTime":"2026-04-17 20:55","pubTimestamp":1776430500,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"21024582","market":"hk","labels":[],"media":"港交所","original_id":"N.HKEnJZbfW3VJ","pdf_url":"https://static.tigerbbs.com/cb80db131a3e4feabcbd9ea90fd86bf7","pub_time":1776430380000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2025年度报告","symbol":"02228","title":"2025年度报告","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2026/0417/2026041701552_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [年报 / 环境、社会及管治资料/报告]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"年度报告","pubTime":"2026-04-17 20:53","pubTimestamp":1776430380,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20882806","market":"hk","labels":[],"media":"港交所","original_id":"N.HK7AnYFRAYBq","pdf_url":"https://static.tigerbbs.com/469f490ba0aa429db81a7ca6999de348","pub_time":1774433880000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"截至2025年12月31日止年度的年度业绩公告","symbol":"02228","title":"截至2025年12月31日止年度的年度业绩公告","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2026/0325/2026032501036_c.pdf","us_notice_code":"公告及通告 - [末期业绩]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"年度报告","pubTime":"2026-03-25 18:18","pubTimestamp":1774433880,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20789101","market":"hk","labels":[],"media":"港交所","original_id":"N.HKEoi6K1CA4P","pdf_url":"https://static.tigerbbs.com/624382e7d5944af4918e2c8bb786cfd9","pub_time":1772532000000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"正面盈利预告扭亏为盈","symbol":"02228","title":"正面盈利预告扭亏为盈","titleType":"业绩预告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2026/0303/2026030301646_c.pdf","us_notice_code":"公告及通告 - [盈利警告 / 内幕消息]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Earnings Estimation","event_type":"important_notice","event_name":"业绩预告","pubTime":"2026-03-03 18:00","pubTimestamp":1772532000,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20669990","market":"hk","labels":[],"media":"港交所","original_id":"N.HKAagr7f4MeA","pdf_url":"https://static.tigerbbs.com/8e2284ffb0a641608e4f658070a8d3aa","pub_time":1769595780000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"完成发行2,866,000,000港元于2027年到期的零息可转换债券","symbol":"02228","title":"完成发行2,866,000,000港元于2027年到期的零息可转换债券","titleType":"股份发行","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2026/0128/2026012800648_c.pdf","us_notice_code":"公告及通告 - [发行可转换证券 / 根据一般性授权发行股份]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Issuance","event_type":"important_notice","event_name":"股份发行","pubTime":"2026-01-28 18:23","pubTimestamp":1769595780,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20613566","market":"hk","labels":[],"media":"港交所","original_id":"N.HKpFZCS5oMAD","pdf_url":"https://static.tigerbbs.com/d6ba8be361e145fa89bb24fe3209cc6a","pub_time":1767826200000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"建议发行2,866,000,000港元于2027年到期的零息可转换债券","symbol":"02228","title":"建议发行2,866,000,000港元于2027年到期的零息可转换债券","titleType":"股份发行","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2026/0108/2026010800042_c.pdf","us_notice_code":"公告及通告 - [发行可转换证券 / 根据一般性授权发行股份]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Issuance","event_type":"important_notice","event_name":"股份发行","pubTime":"2026-01-08 06:50","pubTimestamp":1767826200,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20173334","market":"hk","labels":[],"media":"港交所","original_id":"N.HK2NG2aVqHUH","pdf_url":"https://static.tigerbbs.com/81513848524a4cff837ccefaeddc7c75","pub_time":1758017340000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2025中期报告","symbol":"02228","title":"2025中期报告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0916/2025091600967_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [中期/半年度报告]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2025-09-16 18:09","pubTimestamp":1758017340,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20173157","market":"hk","labels":[],"media":"港交所","original_id":"N.HK9CcnPXRvWr","pdf_url":"https://static.tigerbbs.com/464bf940313f4110b5256b74bb451a75","pub_time":1758015480000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"有关截至2025年6月30日止六个月的中期业绩公告的澄清公告","symbol":"02228","title":"有关截至2025年6月30日止六个月的中期业绩公告的澄清公告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0916/2025091600877_c.pdf","us_notice_code":"公告及通告 - [中期业绩]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2025-09-16 17:38","pubTimestamp":1758015480,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20127960","market":"hk","labels":[],"media":"港交所","original_id":"N.HK5uPwhddh4N","pdf_url":"https://static.tigerbbs.com/0ed7f5f3197248879b2ce690495f6532","pub_time":1756978200000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"完成根据一般授权配售新股份","symbol":"02228","title":"完成根据一般授权配售新股份","titleType":"股份发行","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0904/2025090401265_c.pdf","us_notice_code":"公告及通告 - [配售 / 根据一般性授权发行股份]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Issuance","event_type":"important_notice","event_name":"股份发行","pubTime":"2025-09-04 17:30","pubTimestamp":1756978200,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20097849","market":"hk","labels":[],"media":"港交所","original_id":"N.HKHz6WwQom6t","pdf_url":"https://static.tigerbbs.com/1d463f3b4c3048008f5b11e85aa65bd1","pub_time":1756426560000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"根据一般授权配售新股份","symbol":"02228","title":"根据一般授权配售新股份","titleType":"股份发行","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0829/2025082900312_c.pdf","us_notice_code":"公告及通告 - [配售 / 根据一般性授权发行股份]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Issuance","event_type":"important_notice","event_name":"股份发行","pubTime":"2025-08-29 08:16","pubTimestamp":1756426560,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20068769","market":"hk","labels":[],"media":"港交所","original_id":"N.HK8wg8kqwQGB","pdf_url":"https://static.tigerbbs.com/b22ada1d864c42d594b4ff0fffc892cd","pub_time":1756289400000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"截至2025年6月30日止六个月的中期业绩公告","symbol":"02228","title":"截至2025年6月30日止六个月的中期业绩公告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0827/2025082701124_c.pdf","us_notice_code":"公告及通告 - [中期业绩]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2025-08-27 18:10","pubTimestamp":1756289400,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19973118","market":"hk","labels":[],"media":"港交所","original_id":"N.HK2EiNd9dsQV","pdf_url":"https://static.tigerbbs.com/ad28295d8114435c95c09364a773b8bb","pub_time":1754949960000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"正面盈利预告","symbol":"02228","title":"正面盈利预告","titleType":"业绩预告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0812/2025081200010_c.pdf","us_notice_code":"公告及通告 - [盈利警告 / 内幕消息]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Earnings Estimation","event_type":"important_notice","event_name":"业绩预告","pubTime":"2025-08-12 06:06","pubTimestamp":1754949960,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19626106","market":"hk","labels":[],"media":"港交所","original_id":"N.HK27zCzSG9a4","pdf_url":"https://static.tigerbbs.com/fac64624a5bd419b91583d0552740168","pub_time":1746957900000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"有关收购目标公司90%股权之须予披露交易","symbol":"02228","title":"有关收购目标公司90%股权之须予披露交易","titleType":"须予披露的交易","type":"hkTrade","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0511/2025051100004_c.pdf","us_notice_code":"公告及通告 - [须予披露的交易]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"交易相关","type_name_en":"Transaction Related","titleTypeEn":"","event_type":"important_notice","event_name":"须予披露的交易","pubTime":"2025-05-11 18:05","pubTimestamp":1746957900,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19356689","market":"hk","labels":[],"media":"港交所","original_id":"N.HKGfVm67qcMV","pdf_url":"https://static.tigerbbs.com/664ac2d91e4c4411b9354c87cea0e1a7","pub_time":1744027920000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"建议授出一般授权以发行股份及购回股份、重新委任核数师、重选董事及股东周年大会通告","symbol":"02228","title":"建议授出一般授权以发行股份及购回股份、重新委任核数师、重选董事及股东周年大会通告","titleType":"股份购回","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0407/2025040702158_c.pdf","us_notice_code":"通函 - [一般性授权 / 在股东批准的情况下重选或委任董事 / 回购股份的说明函件]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Repurchase","event_type":"important_notice","event_name":"股份购回","pubTime":"2025-04-07 20:12","pubTimestamp":1744027920,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19356566","market":"hk","labels":[],"media":"港交所","original_id":"N.HK6dbr3AVfgG","pdf_url":"https://static.tigerbbs.com/5cb4a975ab424720844de70d5000f5cf","pub_time":1744027380000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2024年度报告","symbol":"02228","title":"2024年度报告","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0407/2025040702144_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [年报 / 环境、社会及管治资料/报告]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"年度报告","pubTime":"2025-04-07 20:03","pubTimestamp":1744027380,"notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":false},"companyData":{"profile":{"websiteUrl":"https://www.xtalpi.com","stockEarnings":[{"period":"1week","weight":0.03},{"period":"1month","weight":0.0495},{"period":"3month","weight":-0.2289},{"period":"6month","weight":-0.1002},{"period":"1year","weight":1.1912},{"period":"ytd","weight":0.0539}],"compareEarnings":[{"period":"1week","weight":0.0238},{"period":"1month","weight":0.0479},{"period":"3month","weight":-0.0037},{"period":"6month","weight":0.02},{"period":"1year","weight":0.238},{"period":"ytd","weight":0.0334}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"晶泰控股有限公司是一家主要从事为制药及材料科学等产业提供药物及材料科学研发解决方案及服务的控股公司。该公司主要经营两个业务。药物发现解决方案业务从事就新型药物发现工作为各类生物技术与制药公司和学术机构提供模块独立解决方案或与之合作。智能自动化解决方案业务从事提供固态研发服务及自动化化学合成服务。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.06643},{"month":2,"riseRate":0.285714,"avgChangeRate":0.016028},{"month":3,"riseRate":0,"avgChangeRate":-0.069153},{"month":4,"riseRate":0.666667,"avgChangeRate":0.048494},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.010585},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.023767},{"month":7,"riseRate":0.428571,"avgChangeRate":0.047576},{"month":8,"riseRate":0.5,"avgChangeRate":-0.032189},{"month":9,"riseRate":0.8,"avgChangeRate":0.065839},{"month":10,"riseRate":0.6,"avgChangeRate":0.092453},{"month":11,"riseRate":0.5,"avgChangeRate":0.05299},{"month":12,"riseRate":0.5,"avgChangeRate":-0.011625}],"exchange":"SEHK","name":"晶泰控股","nameEN":"XTALPI"},"aProfile":null}}}